# Enclony

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/enclony

- Industry: Medical Devices & Equipment
- Headquarters: Seoul, South Korea
- Website: www.enclony.com
- Total disclosed funding: $6.8M
- Latest round: Series C (Dec 31, 2021)
- Investors on record: 4

## About

Founded in 2013 and based in Seoul, South Korea, Enclony Inc. operates as a provider of medical equipment that helps pharmaceutical companies identify defective tablets and capsules.

The company provides inspection machines for tablets and capsules. The inspection machine inspects the total surface at 360 degrees and supports basic forms such as round and oblong shapes, and special forms such as heart, triangle, and octagon shapes. The inspection machine also can automatically classify tablets and capsules into good, defective, uninspected, and inspected. Operators can perform through the touch monitor.

## Funding rounds

- Series C, Dec 31, 2021, $4.2M — Industrial Bank of Korea, BNH Investment, Samsung Securities
- Series B, Aug 11, 2017, $2.6M — AJU IB Investment, BNH Investment

## Investors

- AJU IB Investment (https://capitalatlas.ai/funds/aju-ib-investment) — Series B
- BNH Investment (https://capitalatlas.ai/funds/bnh-investment) — Series B, Series C
- Industrial Bank of Korea — Series C
- Samsung Securities — Series C